The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
/in Dendritic Cells, International Publications, Prostate Cancer /von 2016-12-20 / J Immunother Cancer 2016;4:92In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia
/in Hyperthermia, International Publications /von 2016-12-20 / Oncotarget 2016 Dec;7(51):84082-84092Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 DCIS Independent of Route: Results of Randomized Selection Design Trial
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-12-13 / Clin Cancer Res 2017 Jun;23(12):2961-2971Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
/in Acute Leukemia, Dendritic Cells, International Publications /von 2016-12-07 / Sci Transl Med 2016 12;8(368):368ra171Emerging role of immunotherapy in urothelial carcinoma-Advanced disease
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-12-01 / Urol Oncol 2016 12;34(12):538-547
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution